Personal Protective Equipment Use and Surface Contamination With Antineoplastic Drugs: The Impact of the COVID-19 Pandemic

Clin J Oncol Nurs. 2024 Jul 19;28(4):380-388. doi: 10.1188/24.CJON.380-388.

Abstract

Background: Surface contamination with antineoplastic drugs (ADs) is persistent. The use of personal protective equipment (PPE) is recommended to reduce exposure to ADs.

Objectives: This study explored the impact of the COVID-19 pandemic on nurses' PPE use and surface contamination with ADs.

Methods: Demographic characteristics, PPE use, and associated factors were assessed on two inpatient oncology units where etoposide and cyclophosphamide were administered before (N = 26) and during the COVID-19 pandemic (N = 31).

Findings: PPE use when handling contaminated excreta was significantly higher during the pandemic. Perceived risk of chemotherapy exposure was significantly associated with greater PPE use when handling AD-contaminated excreta, and conflict of interest was related to less PPE use during AD administration and handling of AD-contaminated excreta. During the pandemic, surface contamination with etoposide increased in shared areas and decreased in patient rooms.

Keywords: antineoplastic drugs; personal protective equipment; surface contamination.

MeSH terms

  • Adult
  • Antineoplastic Agents* / therapeutic use
  • COVID-19* / prevention & control
  • Cyclophosphamide / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nursing Staff, Hospital
  • Occupational Exposure / prevention & control
  • Oncology Nursing / standards
  • Pandemics
  • Personal Protective Equipment*
  • SARS-CoV-2

Substances

  • Antineoplastic Agents
  • Etoposide
  • Cyclophosphamide